Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Itraconazole on the Pharmacokinetics of Engasertib in Healthy Participants
NCT07800429Phase 1Active, not recruiting
- Sponsor
- Vaderis Therapeutics AG
- Start
- Sep 2026
- Primary completion
- Oct 2026
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of engasertib, sponsored by Vaderis Therapeutics AG. Primary endpoints: Area Under the Concentration-time Curve from Zero to the Last Quantifiable Concentration, Area Under the Concentration-time Curve from Zero to Infinity and 1 more. Started Sep 2026; status: active, not recruiting.
02
Drugs
engasertib
Beyond the preview
Go deeper on NCT07800429.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07800429.